Observational studyClinical nephrology2025
24-years' experience of peritoneal dialysis in a university hospital dialysis center: Management and outcome.
Observational study in Clinical nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of our study was to analyze the results of peritoneal dialysis (PD) treatment in all patients treated with PD in our dialysis center. MATERIALS AND
methodsThis is a retrospective observational study in which we included all PD patients from the start of PD treatment in 2000 until the end of follow-up on 30 September 2024.
resultsDuring an observation period of 24 years, 89 patients started PD treatment. Two patients who started PD treatment due to heart failure were excluded. The mean age of the patients was 47 ± 14 years, 61 (70.1%) were men. During PD treatment, 30 (34.5%) patients developed PD-related peritonitis after a median PD duration of 1,174 ± 936 days. During follow-up, 27 (31%) were converted to hemodialysis, 24 (27.6%) received a kidney transplant, 15 (17.2%) patients died during PD treatment, and the remaining 21 patients were still being treated with PD at the end of follow-up. The median duration of PD for all patients was 1,414 ± 1,253 days. Cardiovascular disease (50%) and infection (50%) were the most common causes of death among patients. The comparison between surviving and deceased PD patients showed that surviving patients had a higher baseline serum albumin level (37.7 vs. 34.5 g/L; p = 0.004). The Kaplan-Meier survival analysis showed a worse outcome for diabetics (log rank (Mantel-Cox) = 5.457; p = 0.019).
conclusionCardiovascular disease and infection were common causes of death in PD patients. Peritonitis was the most common cause of PD discontinuation. Diabetics undergoing PD had a poorer survival rate. The average duration of PD treatment was 3.9 years. The average time until the first peritonitis was 3.2 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.